[{"question": "Healing of socket in which flaps are approximated following removal of tooth occurs by:", "correct_answer": "Primary intention.", "correct_idx": 0, "options": ["A)Primary intention.", "B)Secondary intention.", "C)Delayed healing.", "D)Tertiary intention."], "prompt": "Healing of socket in which flaps are approximated following removal of tooth occurs by:A)Primary intention.\nB)Secondary intention.\nC)Delayed healing.\nD)Tertiary intention.", "subject_name": "Surgery", "output0": "The healing of the socket in which flaps are approximated following the removal of a tooth occurs by primary intention. This is because the flaps are placed in the socket and are allowed to heal without any further intervention. This approach allows for the socket to heal naturally and is often associated with better healing outcomes.\n\n", "output1": "The healing of the socket in which flaps are approximated following the removal of a tooth occurs by secondary intention. This means that the socket will heal through the formation of granulation tissue, which is a type of connective tissue that forms in the wound and helps to promote healing.\n\n", "output2": "The healing of the socket in which flaps are approximated following the removal of a tooth occurs by delayed healing. This is because the socket is allowed to heal by secondary intention, which means that the wound is allowed to close on its own, rather than being closed intentionally by sutures or stitches.\n\n", "output3": "The healing of the socket in which flaps are approximated following the removal of a tooth occurs by tertiary intention, which is a slower and more deliberate healing process that occurs over a longer period of time. This approach allows for the formation of new tissue and the development of a more stable socket before the flaps are approximated.\n\n"}, {"question": "The conversion of glucose-6-P to fructose-6-P is an example of which of the following reactions:", "correct_answer": "Isomerisation", "correct_idx": 1, "options": ["A)Phosphate transfer", "B)Isomerisation", "C)Dehydration", "D)Aldol cleavage"], "prompt": "The conversion of glucose-6-P to fructose-6-P is an example of which of the following reactions:A)Phosphate transfer\nB)Isomerisation\nC)Dehydration\nD)Aldol cleavage", "subject_name": "Biochemistry", "output0": "The conversion of glucose-6-P to fructose-6-P is an example of a phosphate transfer reaction. In this reaction, a phosphate group is transferred from glucose-6-P to fructose-6-P, resulting in the formation of fructose-6-P.\n\n", "output1": "The conversion of glucose-6-P to fructose-6-P is an example of isomerisation, which is a type of chemical reaction in which two molecules are converted into one another. In this case, the glucose-6-P molecule is converted into a fructose-6-P molecule through the rearrangement of its atoms.\n\n", "output2": "The conversion of glucose-6-P to fructose-6-P involves the loss of a water molecule, which is a dehydration reaction.\n\n", "output3": "The conversion of glucose-6-P to fructose-6-P is an example of an aldol cleavage reaction. This type of reaction involves the breakage of a glycosidic bond between two sugars, resulting in the formation of two new sugars.\n\n"}, {"question": "Which of the following is true about Chi-square test?", "correct_answer": "Measures the qualitative data between two proportion", "correct_idx": 2, "options": ["A)Measures qualitative data", "B)Measures both qualitative and quantitative data", "C)Measures the qualitative data between two proportion", "D)Measure the quantitative data between two proportion"], "prompt": "Which of the following is true about Chi-square test?A)Measures qualitative data\nB)Measures both qualitative and quantitative data\nC)Measures the qualitative data between two proportion\nD)Measure the quantitative data between two proportion", "subject_name": "Dental", "output0": "The Chi-square test is a statistical technique used to measure the relationship between qualitative data. It is not used to measure quantitative data or the relationship between two quantitative variables. Therefore, option A is the correct answer.\n\n", "output1": "The Chi-square test is a statistical test that measures the association between two categorical variables. It can be used to compare both qualitative and quantitative data. Therefore, option B is the correct answer.\n\n", "output2": "The Chi-square test measures the relationship between two qualitative variables. It helps to determine whether there is a significant association between two categorical variables.\n\n", "output3": "The Chi-square test measures the quantitative data between two proportions to determine whether there is a significant association or difference between the two groups. It is commonly used to analyze data in social sciences, such as comparing the distribution of a particular characteristic among two groups.\n\n"}, {"question": "About Juvenile Myoclonic epilepsy, all are true EXCEPT:", "correct_answer": "Valproate is contraindicated", "correct_idx": 0, "options": ["A)Valproate is contraindicated", "B)Lamotrigine can be given", "C)Phenytoin is not the preferred drug", "D)Polygenic inheritance"], "prompt": "About Juvenile Myoclonic epilepsy, all are true EXCEPT:A)Valproate is contraindicated\nB)Lamotrigine can be given\nC)Phenytoin is not the preferred drug\nD)Polygenic inheritance", "subject_name": "Pediatrics", "output0": "Valproate is contraindicated in patients with Juvenile Myoclonic Epilepsy because it can exacerbate the seizures.\n\n", "output1": "Lamotrigine is not a preferred drug for the treatment of Juvenile Myoclonic Epilepsy. It has been associated with increased risk of adverse events and is not as effective as other medications, such as valproate and levetiracetam.\n\n", "output2": "Phenytoin is not the preferred drug for the treatment of Juvenile Myoclonic Epilepsy because it is not effective in controlling the type of seizures that occur in this condition. Other medications, such as valproate and lamotrigine, are more effective in managing the seizures associated with Juvenile Myoclonic Epilepsy.\n\n", "output3": "Polygenic inheritance is not a true statement about Juvenile Myoclonic epilepsy. This condition is not caused by a single gene mutation, but rather by a complex interplay of genetic and environmental factors.\n\n"}, {"question": "True about bisphosphonate mechanism of action", "correct_answer": "Inhibit osteoclast mediated resorption", "correct_idx": 0, "options": ["A)Inhibit osteoclast mediated resorption", "B)Increases rate of osteoid formation", "C)Increases mineralization of osteoid", "D)All of above"], "prompt": "True about bisphosphonate mechanism of actionA)Inhibit osteoclast mediated resorption\nB)Increases rate of osteoid formation\nC)Increases mineralization of osteoid\nD)All of above", "subject_name": "Dental", "output0": "Bisphosphonates work by inhibiting the activity of osteoclasts, which are the cells responsible for resorbing bone. By inhibiting osteoclast activity, bisphosphonates reduce the rate of bone resorption, leading to an increase in bone density.\n\n", "output1": "Bisphosphonates increase the rate of osteoid formation, which is the process by which bone tissue is formed. This is done by inhibiting the activity of osteoclasts, which are cells that break down bone tissue. By reducing the activity of osteoclasts, bisphosphonates allow for a greater amount of osteoid to be formed, leading to increased bone density and strength.\n\n", "output2": "Bisphosphonates inhibit osteoclast mediated resorption, which leads to an increase in mineralization of osteoid. This is the mechanism of action of bisphosphonates.\n\n", "output3": "Bisphosphonates have multiple mechanisms of action, including inhibiting osteoclast-mediated resorption, increasing the rate of osteoid formation, and increasing mineralization of osteoid. Therefore, the correct answer is D)All of above.\n\n"}, {"question": "A 34-year-old woman, gravida 2, para 1, at 34 weeks' gestation comes to the physician because of a 10-day history of generalized pruritus and a 2-day history of jaundice, dark urine, and pale stools. She had developed pruritus at the end of her previous pregnancy, which disappeared after delivery. She has had standard prenatal care. Medications include folic acid and a multivitamin. Her blood pressure is 108/60 mm Hg. Examination shows scleral icterus, jaundice, and scratch marks on her upper and lower limbs. Pelvic examination shows a uterus consistent in size with a 30-week gestation.\nHemoglobin 11.5 g/dl\nPlatelet 350,000/mm3\nProthrombin time 11 seconds (INR=1)\nSerum\nTotal bilirubin 5 mg/dl\nDirect bilirubin 4.2 mg/dl\nBile acid\n25 \u03bcmol/l (N= 0.3 to 10 \u03bcmol/l)\nAspartate aminotransferase 55 U/L\nAlanine aminotransferase 45 U/L\nThere are no abnormalities on abdominopelvic ultrasonography. Which of the following is the most appropriate next step in management?\"", "correct_answer": "Ursodeoxycholic acid", "correct_idx": 3, "options": ["A)24-hour urine protein", "B)Emergency endoscopic retrograde cholangiopancreatography and sphincterotomy", "C)Immediate induction of labor", "D)Ursodeoxycholic acid"], "prompt": "A 34-year-old woman, gravida 2, para 1, at 34 weeks' gestation comes to the physician because of a 10-day history of generalized pruritus and a 2-day history of jaundice, dark urine, and pale stools. She had developed pruritus at the end of her previous pregnancy, which disappeared after delivery. She has had standard prenatal care. Medications include folic acid and a multivitamin. Her blood pressure is 108/60 mm Hg. Examination shows scleral icterus, jaundice, and scratch marks on her upper and lower limbs. Pelvic examination shows a uterus consistent in size with a 30-week gestation.\nHemoglobin 11.5 g/dl\nPlatelet 350,000/mm3\nProthrombin time 11 seconds (INR=1)\nSerum\nTotal bilirubin 5 mg/dl\nDirect bilirubin 4.2 mg/dl\nBile acid\n25 \u03bcmol/l (N= 0.3 to 10 \u03bcmol/l)\nAspartate aminotransferase 55 U/L\nAlanine aminotransferase 45 U/L\nThere are no abnormalities on abdominopelvic ultrasonography. Which of the following is the most appropriate next step in management?\"A)24-hour urine protein\nB)Emergency endoscopic retrograde cholangiopancreatography and sphincterotomy\nC)Immediate induction of labor\nD)Ursodeoxycholic acid", "subject_name": null, "output0": "The most appropriate next step in management is to perform a 24-hour urine protein collection. This is because the patient's history of pruritus and jaundice, along with the laboratory results (elevated bilirubin and liver enzymes), suggest a diagnosis of obstetric cholestasis. This condition is characterized by a decreased ability of the liver to secrete bile, which leads to increased levels of bilirubin and bile acids in the blood.\n\n", "output1": "The most appropriate next step in management for this patient is emergency endoscopic retrograde cholangiopancreatography and sphincterotomy (ERCP&S). The patient's symptoms of jaundice, dark urine, and pale stools, along with the high level of bilirubin and bile acids in her blood, suggest that she has a bile duct obstruction, which is a medical emergency. ERCP&S is the most effective method for diagnosing and treating this condition.\n\n", "output2": "The most appropriate next step in management for this patient is immediate induction of labor. The patient's symptoms of jaundice, dark urine, and pale stools, along with her history of previous pregnancy-related jaundice, suggest that she has intrahepatic cholestasis of pregnancy (ICP), which can lead to complications such as fetal distress and meconium staining. Immediate induction of labor is necessary to prevent these complications and ensure the safety of the mother and the baby.\n\n", "output3": "Ursodeoxycholic acid is the most appropriate next step in management because the patient's symptoms of jaundice, dark urine, and pale stools, along with her history of previous gestational jaundice, are consistent with intrahepatic cholestasis of pregnancy (ICP). Ursodeoxycholic acid is a medication that is commonly used to treat ICP.\n\n"}, {"question": "The cofactor vitamin B12 is required for the following conversion:", "correct_answer": "Methyl malonyl CoA to succinyl CoA", "correct_idx": 2, "options": ["A)Dopamine to Norepinephrine", "B)Propionyl CoA to methyl malonyl CoA", "C)Methyl malonyl CoA to succinyl CoA", "D)Cysteine to homocysteine"], "prompt": "The cofactor vitamin B12 is required for the following conversion:A)Dopamine to Norepinephrine\nB)Propionyl CoA to methyl malonyl CoA\nC)Methyl malonyl CoA to succinyl CoA\nD)Cysteine to homocysteine", "subject_name": "Biochemistry", "output0": "The cofactor vitamin B12 is required for the conversion of dopamine to norepinephrine. This conversion is an important step in the synthesis of neurotransmitters in the brain.\n\n", "output1": "The cofactor vitamin B12 is required for the conversion of Propionyl CoA to methyl malonyl CoA. This conversion is an important step in the synthesis of fatty acids and amino acids.\n\n", "output2": "The cofactor vitamin B12 is required for the conversion of methyl malonyl CoA to succinyl CoA. This conversion is an important step in the synthesis of fatty acids.\n\n", "output3": "The cofactor vitamin B12 is required for the conversion of cysteine to homocysteine. This is a crucial step in the synthesis of proteins and other biomolecules.\n\n"}, {"question": "A non-superimposable molecule with its mirror image is defined as:", "correct_answer": "Chiral.", "correct_idx": 1, "options": ["A)Enantiomeric", "B)Chiral.", "C)Diastereomeric", "D)Mesomer"], "prompt": "A non-superimposable molecule with its mirror image is defined as:A)Enantiomeric\nB)Chiral.\nC)Diastereomeric\nD)Mesomer", "subject_name": "chemistry", "output0": "A non-superimposable molecule with its mirror image is defined as enantiomeric. This means that the molecule and its mirror image are not superimposable, meaning they cannot be overlaid on top of each other. This is because the molecule has a non-superimposable mirror image.\n\n", "output1": "A chiral molecule is one that cannot be superimposed on its mirror image. This property is due to the presence of one or more asymmetric centers in the molecule. Enantiomers, diastereomers, and mesomers are all types of chiral molecules.\n\n", "output2": "A non-superimposable molecule with its mirror image is defined as diastereomeric. This means that the molecule and its mirror image cannot be superimposed on each other, even though they may have the same molecular formula and structure.\n\n", "output3": "A non-superimposable molecule with its mirror image is defined as a diastereomer. Diastereomers are molecules that have the same molecular formula but differ in their three-dimensional structure, and are not superimposable on each other.\n\n"}, {"question": "A 65-year-old male presents to his pulmonologist for a follow-up visit. He has a history of chronic progressive dyspnea over the past five years. He uses oxygen at home and was seen in the emergency room two months prior for an exacerbation of his dyspnea. He was discharged following stabilization. His past medical history is notable for hyperlipidemia and hypertension. He drinks alcohol socially and has a 45 pack-year smoking history. His temperature is 98.6\u00b0F (37\u00b0C), blood pressure is 140/75 mmHg, pulse is 110/min, and respirations are 22/min. On examination, increased work of breathing is noted. The physician decides to start the patient on an additional medication that has both mucoactive and anti-oxidative properties. What is the primary mechanism of action of this medication in the lungs?", "correct_answer": "Disulfide bond cleavage", "correct_idx": 1, "options": ["A)DNA hydrolysis", "B)Disulfide bond cleavage", "C)Endothelin-1 antagonism", "D)Reduction in airway surface tension"], "prompt": "A 65-year-old male presents to his pulmonologist for a follow-up visit. He has a history of chronic progressive dyspnea over the past five years. He uses oxygen at home and was seen in the emergency room two months prior for an exacerbation of his dyspnea. He was discharged following stabilization. His past medical history is notable for hyperlipidemia and hypertension. He drinks alcohol socially and has a 45 pack-year smoking history. His temperature is 98.6\u00b0F (37\u00b0C), blood pressure is 140/75 mmHg, pulse is 110/min, and respirations are 22/min. On examination, increased work of breathing is noted. The physician decides to start the patient on an additional medication that has both mucoactive and anti-oxidative properties. What is the primary mechanism of action of this medication in the lungs?A)DNA hydrolysis\nB)Disulfide bond cleavage\nC)Endothelin-1 antagonism\nD)Reduction in airway surface tension", "subject_name": null, "output0": "The medication you are referring to is likely a mucoactive agent, which works by breaking down mucus in the lungs. The primary mechanism of action of this medication is DNA hydrolysis, which is the breaking down of DNA in mucus-producing cells. This leads to a reduction in mucus production and an improvement in lung function.\n\n", "output1": "The medication you are describing is likely a bronchodilator, which works by breaking disulfide bonds in the airway surface liquid to thin and loosen mucus, making it easier to cough up. This mechanism of action is responsible for the medication's mucoactive properties. Additionally, the medication may also have anti-oxidative properties, which can help reduce oxidative stress in the lungs and improve lung function.\n\n", "output2": "The medication you are referring to is likely a bronchodilator, which works by blocking the action of endothelin-1 (ET-1) in the lungs. ET-1 is a potent vasoconstrictor and inflammatory mediator that is involved in the pathophysiology of asthma and COPD. By blocking the action of ET-1, bronchodilators can help to relax airway smooth muscle, reduce airway resistance, and improve lung function.\n\n", "output3": "The medication you are referring to is likely a mucolytic agent, which works by breaking down mucus in the airways, reducing its viscosity and making it easier to clear. This action is thought to be the primary mechanism of action of this medication in the lungs, as it helps to reduce the work of breathing and improve lung function.\n\n"}, {"question": "Congenital cataract with visual disturbances surgery should be done ?", "correct_answer": "Immediately", "correct_idx": 0, "options": ["A)Immediately", "B)After 2 months", "C)After 4 months", "D)After 1 year"], "prompt": "Congenital cataract with visual disturbances surgery should be done ?A)Immediately\nB)After 2 months\nC)After 4 months\nD)After 1 year", "subject_name": "Ophthalmology", "output0": "Congenital cataract with visual disturbances should be surgically treated as soon as possible, ideally within the first few weeks of life. Delaying surgery can lead to a higher risk of complications and a lower chance of successful vision recovery.\n\n", "output1": "Congenital cataract surgery should be done after 2 months of age because the child's vision is more stable at this age, and the risk of complications is lower. Additionally, waiting until the child is a bit older can help ensure that the child's brain has fully developed, which can improve the chances of successful surgery and better visual outcomes.\n\n", "output2": "Congenital cataract with visual disturbances surgery should be done after 4 months because at this age, the child's vision is more stable, and the surgery is more likely to be successful. Additionally, the child's visual system is still developing, and the surgery can help to promote healthy visual development.\n\n", "output3": "Congenital cataract with visual disturbances surgery should be done after 1 year because it is important to wait until the child is developmentally ready for the surgery and the potential risks and complications are minimized. Additionally, the child's visual system needs time to develop and mature before the surgery.\n\n"}]